Th. Kwon et al., Reduced abundance of aquaporins in rats with bilateral ischemia-induced acute renal failure: prevention by alpha-MSH, AM J P-REN, 46(3), 1999, pp. F413-F427
We examined the effect of temporary renal ischemia (30 min or 60 min) and r
eperfusion (1 day or 5 days) on the expression of renal aquaporins (AQPs) a
nd urinary concentration in rats with bilateral ischemia-induced acute rena
l failure (ARF). Next, we tested whether reducing ischemia/reperfusion (I/R
) injury by treatment with or-melanocyte stimulating hormone (alpha-MSH) af
fects the expression of AQPs and urine output. Rats with ARF showed signifi
cant renal insufficiency, and urinary concentration was markedly impaired.
In rats with mild ischemic injury (30 min), urine output increased signific
antly to a maximum at 48 h, and then nearly normalized within 5 days. Consi
stent with this, semiquantitative immunoblotting revealed that kidney AQP1
and AQP2 abundance was significantly decreased after 24 h to 30 +/- 5% and
40 +/- 11% (n = 8) of controls (n = 9), respectively (P < 0.05). Five days
after ischemia, AQP2 abundance was not significantly decreased and urine ou
tput was normalized. In contrast, severe ischemic injury (60 min) resulted
in a marked reduction in urine output at 24 h, despite a significant decrea
se in urine osmolality and solute-free water reabsorption, (TH2O)-H-c. AQP1
and AQP2 abundance was markedly decreased to 51 +/- 5% and 31 +/- 9% (n =
10) of controls (n = 8) at 24 h (P ( 0.05). After 5 days, the rats develope
d gradually severe polyuria and had very low AQP2 and AQP1 levels [11 +/- 4
% and 6 +/- 2% (n = 5) of controls (n = 8), respectively; P < 0.05]. A simi
lar reduction was observed for AQP3. The reduction in AQP expression in the
proximal tubule and inner medullary collecting duct was confirmed by immun
ocytochemistry. Next, we found that intravenous (alpha-MSH treatment of rat
s with ARF significantly reduced the ischemia-induced downregulation of ren
al AQPs and reduced the polyuria. In conclusion, the I/R injury is associat
ed with markedly reduced expression of the collecting duct and proximal tub
ule AQPs, in association with an impairment of urinary concentration. Moreo
ver, alpha-MSH treatment significantly prevented the reduction in expressio
n of AQPs and renal functional defects. Thus decreased AQP expression is li
kely to contribute to the impairment in urinary concentration in the postis
chemic period.